Ginkgo Bioworks Holdings, Inc. () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
"main_header": {
"sid": 1289905,
"name": "Ginkgo Bioworks Holdings, Inc.",
"stock_name": "Ginkgo Bioworks Holdings, Inc.",
"full_name": "Ginkgo Bioworks Holdings, Inc.",
"name_url": "stocks-analysis/ginkgo-bioworks-holdings-inc",
"exchange": 207,
"exchangecode": "NYS",
"country_id": 2,
"currency": "USD",
"cmp": "8.24",
"chg": "0.00",
"chgp": "0.00%",
"dir": 0,
"prev_price": "8.24",
"mcapval": "662.45",
"mcap": "Micro Cap",
"scripcode": "",
"symbol": "",
"ind_name": "Pharmaceuticals & Biotechnology",
"ind_code": 3365,
"indexname": "S&P 500",
"isin": "US37611X1000",
"curr_date": "Dec 18",
"curr_time": "",
"bse_nse_vol": "2.08 M",
"exc_status": "Active",
"traded_date": "Dec 18, 2025",
"traded_date_str": "2025 12 18",
"score": "",
"scoreText": "",
"Live": 0,
"market_time": 0,
"is_blur": 1,
"is_blur_class": "blur-register-score-header",
"is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ginkgo-bioworks-holdings-inc-1289905-207&utm_source=Spage_Header_Score",
"mojoone": {
"ismore": 0
}
},
"news": {
"results": [
{
"title": "Ginkgo Bioworks Holdings, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance",
"link": "https://www.marketsmojo.com/news/stocks-in-action/ginkgo-bioworks-holdings-inc-technical-trend-changes-from-bullish-to-mildly-bullish-amid-price-fluctuations-3620030",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/GinkgoBioworksH_technicaldot_3620030.png",
"date": "2025-10-14 16:32:37",
"description": "Ginkgo Bioworks Holdings, Inc. has recently seen a stock price adjustment, currently at $13.16. Over the past year, the company has achieved a remarkable 79.54% return, significantly surpassing the S&P 500. Various technical indicators suggest a mixed outlook, reflecting the company's resilience in the Pharmaceuticals & Biotechnology sector."
},
{
"title": "Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-ginkgo-bioworks-holdings-inc-technically-bullish-or-bearish-3617772",
"imagepath": "",
"date": "2025-10-14 11:40:45",
"description": "As of 10 October 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance, but the KST shows a mildly bearish trend on both weekly and monthly time frames. The Dow Theory supports a mildly bullish outlook for both weekly and monthly periods. \n\nIn terms of returns, Ginkgo Bioworks has outperformed the S&P 500 significantly over the past year, with a return of 79.54% compared to the S&P 500's 13.36%. However, it experienced a sharp decline of 11.5% over the past week, while the S&P 500 fell only 2.43%. Overall, the current technical stance is mildly bullish, driven by the mixed signals from MACD, moving averages, and Dow Theory...."
},
{
"title": "Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-ginkgo-bioworks-holdings-inc-technically-bullish-or-bearish-3614768",
"imagepath": "",
"date": "2025-10-13 11:42:29",
"description": "As of 10 October 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive but weakening momentum. The daily moving averages are bullish, supporting the mildly bullish stance. However, the KST shows a mildly bearish signal on both weekly and monthly time frames, which adds some caution. The Dow Theory confirms a mildly bullish trend on both weekly and monthly levels. \n\nIn terms of performance, Ginkgo Bioworks has significantly outperformed the S&P 500 over the past year with an 88.3% return compared to the S&P's 13.36%. Over three years, the stock has returned 367.82% versus the S&P's 81.39%. Overall, the current technical stance is mildly bullish, driven by the mixed signals from MACD, moving averages, and Dow Theory...."
},
{
"title": "Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-ginkgo-bioworks-holdings-inc-technically-bullish-or-bearish-3613099",
"imagepath": "",
"date": "2025-10-12 11:29:31",
"description": "As of 10 October 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish while the monthly MACD is mildly bullish, indicating some positive momentum. The daily moving averages are bullish, supporting a short-term positive outlook. However, the KST is mildly bearish on both weekly and monthly time frames, which introduces some caution. The Dow Theory aligns with a mildly bullish stance on both weekly and monthly charts. \n\nIn terms of performance, Ginkgo Bioworks has shown strong returns, with a 1-year return of 88.3% compared to the S&P 500's 13.36%, and a 3-year return of 367.82% versus the S&P 500's 81.39%. Overall, the current technical stance is mildly bullish, driven by the mixed signals from MACD, moving averages, and Dow Theory...."
},
{
"title": "Ginkgo Bioworks Experiences Revision in Stock Evaluation Amid Strong Market Performance",
"link": "https://www.marketsmojo.com/news/stocks-in-action/ginkgo-bioworks-holdings-inc-technical-trend-changes-from-mildly-bullish-to-bullish-amid-strong-market-performance-3601429",
"imagepath": "https://i.marketsmojo.com/newsimg/2025/10/GinkgoBioworksH_technicaldot_3601429.png",
"date": "2025-10-07 21:12:07",
"description": "Ginkgo Bioworks Holdings, Inc. has recently revised its evaluation amid changing market conditions. The company's stock has shown significant year-to-date and annual returns, outperforming the S&P 500. Technical indicators present a mixed outlook, reflecting both bullish and mildly bearish trends in the market."
},
{
"title": "Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-ginkgo-bioworks-holdings-inc-technically-bullish-or-bearish-3599433",
"imagepath": "",
"date": "2025-10-07 12:26:58",
"description": "As of 3 October 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the monthly MACD is only mildly bullish, and the KST shows mild bearishness on both weekly and monthly time frames. The Bollinger Bands are mildly bullish on the weekly chart but sideways on the monthly. The Dow Theory indicates a mildly bullish trend on the monthly timeframe, while the weekly shows no trend. Overall, the current technical stance is bullish, with strength primarily driven by the daily moving averages and the weekly MACD. Multi-period return data is not available for comparison with the S&P 500...."
},
{
"title": "Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-ginkgo-bioworks-holdings-inc-technically-bullish-or-bearish-3592231",
"imagepath": "",
"date": "2025-10-05 12:02:44",
"description": "As of 3 October 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish, supported by a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and bullish moving averages on the daily timeframe. Although the KST is mildly bearish on both weekly and monthly, the overall indicators suggest strength in the bullish trend. \n\nIn terms of performance, Ginkgo Bioworks has significantly outperformed the S&P 500 across multiple periods, with a 1-year return of 98.77% compared to the S&P 500's 17.82%, and a 3-year return of 414.01% versus 82.57%...."
},
{
"title": "Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-ginkgo-bioworks-holdings-inc-technically-bullish-or-bearish-3548312",
"imagepath": "",
"date": "2025-09-20 20:14:43",
"description": "As of 2 September 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD indicates a mildly bearish stance, while the monthly MACD is mildly bullish. The daily moving averages are mildly bullish, supporting a positive short-term outlook. However, the weekly Dow Theory shows a mildly bearish signal, contrasting with the monthly which is mildly bullish. \n\nIn terms of returns, the stock has outperformed the S&P 500 over the past week and year, with returns of 9.39% and 54.12% respectively, compared to the S&P 500's 1.05% and 17.14%. Overall, the current technical stance is mildly bullish, driven by mixed signals across different indicators...."
},
{
"title": "Is Ginkgo Bioworks Holdings, Inc. overvalued or undervalued?",
"link": "https://www.marketsmojo.com/news/stocks-in-action/is-ginkgo-bioworks-holdings-inc-overvalued-or-undervalued-3544383",
"imagepath": "",
"date": "2025-09-20 18:44:52",
"description": "As of 16 August 2021, the valuation grade for Ginkgo Bioworks Holdings, Inc. moved from does not qualify to risky, indicating increased concerns about its financial health. The company appears to be overvalued, given its negative P/E ratio and significant losses reflected in its ROE of -60.42%. Key valuation ratios include a Price to Book Value of 0.69, an EV to EBIT of 0.21, and an EV to EBITDA of 0.25, all of which suggest that the company is struggling to generate positive returns relative to its valuation metrics.\n\nIn comparison to peers, Ginkgo Bioworks has a worse EV to EBITDA ratio than Agilon Health, which stands at -0.6626, further highlighting its relative weakness in the industry. Despite a strong 1-year stock return of 54.12% compared to the S&P 500's 17.14%, the company's long-term performance over 3 years shows a dramatic decline of -90.45%, indicating significant volatility and risk...."
}
],
"total": 13,
"sid": "1289905",
"stock_news_url": "https://www.marketsmojo.com/news/ginkgo-bioworks-holdings-inc-1289905"
},
"announcements": "",
"corporate_actions": {
"msg": "No corporate action Found"
}
}

News and Views

Ginkgo Bioworks Holdings, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance

2025-10-14 16:32:37

Ginkgo Bioworks Holdings, Inc. has recently seen a stock price adjustment, currently at $13.16. Over the past year, the company has achieved a remarkable 79.54% return, significantly surpassing the S&P 500. Various technical indicators suggest a mixed outlook, reflecting the company's resilience in the Pharmaceuticals & Biotechnology sector.

Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?

2025-10-14 11:40:45

As of 10 October 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish. The daily moving averages indicate a bullish stance, but the KST shows a mildly bearish trend on both weekly and monthly time frames. The Dow Theory supports a mildly bullish outlook for both weekly and monthly periods. In terms of returns, Ginkgo Bioworks has outperformed the S&P 500 significantly over the past year, with a return of 79.54% compared to the S&P 500's 13.36%. However, it experienced a sharp decline of 11.5% over the past week, while the S&P 500 fell only 2.43%. Overall, the current technical stance is mildly bullish, driven by the mixed signals from MACD, moving averages, and Dow Theory....

Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?

2025-10-13 11:42:29

As of 10 October 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish, while the monthly MACD is mildly bullish, indicating a positive but weakening momentum. The daily moving averages are bullish, supporting the mildly bullish stance. However, the KST shows a mildly bearish signal on both weekly and monthly time frames, which adds some caution. The Dow Theory confirms a mildly bullish trend on both weekly and monthly levels. In terms of performance, Ginkgo Bioworks has significantly outperformed the S&P 500 over the past year with an 88.3% return compared to the S&P's 13.36%. Over three years, the stock has returned 367.82% versus the S&P's 81.39%. Overall, the current technical stance is mildly bullish, driven by the mixed signals from MACD, moving averages, and Dow Theory....

Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?

2025-10-12 11:29:31

As of 10 October 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD is bullish while the monthly MACD is mildly bullish, indicating some positive momentum. The daily moving averages are bullish, supporting a short-term positive outlook. However, the KST is mildly bearish on both weekly and monthly time frames, which introduces some caution. The Dow Theory aligns with a mildly bullish stance on both weekly and monthly charts. In terms of performance, Ginkgo Bioworks has shown strong returns, with a 1-year return of 88.3% compared to the S&P 500's 13.36%, and a 3-year return of 367.82% versus the S&P 500's 81.39%. Overall, the current technical stance is mildly bullish, driven by the mixed signals from MACD, moving averages, and Dow Theory....

Ginkgo Bioworks Experiences Revision in Stock Evaluation Amid Strong Market Performance

2025-10-07 21:12:07

Ginkgo Bioworks Holdings, Inc. has recently revised its evaluation amid changing market conditions. The company's stock has shown significant year-to-date and annual returns, outperforming the S&P 500. Technical indicators present a mixed outlook, reflecting both bullish and mildly bearish trends in the market.

Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?

2025-10-07 12:26:58

As of 3 October 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the monthly MACD is only mildly bullish, and the KST shows mild bearishness on both weekly and monthly time frames. The Bollinger Bands are mildly bullish on the weekly chart but sideways on the monthly. The Dow Theory indicates a mildly bullish trend on the monthly timeframe, while the weekly shows no trend. Overall, the current technical stance is bullish, with strength primarily driven by the daily moving averages and the weekly MACD. Multi-period return data is not available for comparison with the S&P 500....

Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?

2025-10-05 12:02:44

As of 3 October 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from mildly bullish to bullish. The current technical stance is bullish, supported by a bullish MACD on the weekly timeframe, bullish Bollinger Bands on both weekly and monthly timeframes, and bullish moving averages on the daily timeframe. Although the KST is mildly bearish on both weekly and monthly, the overall indicators suggest strength in the bullish trend. In terms of performance, Ginkgo Bioworks has significantly outperformed the S&P 500 across multiple periods, with a 1-year return of 98.77% compared to the S&P 500's 17.82%, and a 3-year return of 414.01% versus 82.57%....

Is Ginkgo Bioworks Holdings, Inc. technically bullish or bearish?

2025-09-20 20:14:43

As of 2 September 2025, the technical trend for Ginkgo Bioworks Holdings, Inc. has changed from bullish to mildly bullish. The weekly MACD indicates a mildly bearish stance, while the monthly MACD is mildly bullish. The daily moving averages are mildly bullish, supporting a positive short-term outlook. However, the weekly Dow Theory shows a mildly bearish signal, contrasting with the monthly which is mildly bullish. In terms of returns, the stock has outperformed the S&P 500 over the past week and year, with returns of 9.39% and 54.12% respectively, compared to the S&P 500's 1.05% and 17.14%. Overall, the current technical stance is mildly bullish, driven by mixed signals across different indicators....

Is Ginkgo Bioworks Holdings, Inc. overvalued or undervalued?

2025-09-20 18:44:52

As of 16 August 2021, the valuation grade for Ginkgo Bioworks Holdings, Inc. moved from does not qualify to risky, indicating increased concerns about its financial health. The company appears to be overvalued, given its negative P/E ratio and significant losses reflected in its ROE of -60.42%. Key valuation ratios include a Price to Book Value of 0.69, an EV to EBIT of 0.21, and an EV to EBITDA of 0.25, all of which suggest that the company is struggling to generate positive returns relative to its valuation metrics. In comparison to peers, Ginkgo Bioworks has a worse EV to EBITDA ratio than Agilon Health, which stands at -0.6626, further highlighting its relative weakness in the industry. Despite a strong 1-year stock return of 54.12% compared to the S&P 500's 17.14%, the company's long-term performance over 3 years shows a dramatic decline of -90.45%, indicating significant volatility and risk....

View All News